Skip to main content

A Dentist Inquires About His Patient with Systemic Sclerosis

  • Chapter
  • First Online:
Case Studies in Systemic Sclerosis

Abstract

Systemic sclerosis is a rare autoimmune condition affecting a variety of organ systems. Body surface involvement (of the integumentary system) leads to tightening of the skin involving the face and the intraoral tissues in both limited and diffuse cutaneous systemic sclerosis. Fibrosis of the orofacial complex results in a variety of oral complications including decreased oral aperture, muco-gingival defects, periodontal disease, dental caries, temporomandibular disorder (TMD), and trigeminal neuropathy. Xerostomia is also a common occurrence in these patients, related to medications and secondary Sjogren’s syndrome, among other causes. It is essential to be knowledgeable about the potential oral manifestations and the potential treatment options in this patient population. Due to the significant morbidity related to problems involving the mouth, as clinicians we must remain vigilant to our patients’ needs in this understudied area.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Mayes MD, Reveille JD. Epidemiology, demographics and genetics. In: Clements PJ, Furst DE, eds. Systemic Sclerosis. 2nd ed. Philadelphia: Lippincott; 2004:1-15.

    Google Scholar 

  2. Vincent C, Agard C, Barbarot S, et al. Orofacial manifestations of systemic sclerosis: a study of 30 consecutive patients. Rev Méd Interne. 2009;30(1):5-11.

    Article  PubMed  CAS  Google Scholar 

  3. Porter SR, Scully C, Hegarty AM. An update of the etiology and management of xerostomia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;97(1):28-46.

    Article  PubMed  CAS  Google Scholar 

  4. Dawes C. Salivary flow patterns and the health of hard and soft oral tissues. J Am Dent Assoc. 2008;139(suppl):18S-24S.

    PubMed  Google Scholar 

  5. Garcia-Godoy F, Hicks MJ. Maintaining the integrity of the enamel surface: the role of dental biofilm, saliva and preventive agents in enamel demineralization and remineralization. J Am Dent Assoc. 2008;139(suppl):25S-34S.

    PubMed  Google Scholar 

  6. Hicks J, Garcia-Godoy F, Flaitz C. Biological factors in dental caries: role of saliva and dental plaque in the dynamic process of demineralization and remineralization (part 1). J Clin Pediatr Dent. 2003;28(1):47-52.

    PubMed  Google Scholar 

  7. Bultzinglowen V. Salivary dysfunction associated with systemic diseases: systemic review and clinical management recommendations. Oral Surg Oral Med Oral Pathol. 2007;103(1):1-15.

    Google Scholar 

  8. Napenas JJ, Brennan MT, Fox PC. Diagnosis and treatment of xerostomia (dry mouth). Odontology. 2009;97(2):76-83.

    Article  PubMed  Google Scholar 

  9. Klasser GD, Balasubramaniam R, Epstein J. Topical review-connective tissue diseases: orofacial manifestations including pain. J Orofac Pain. 2007;21(3):171-184.

    PubMed  Google Scholar 

  10. Guggenheimer J, Moore PA. Xerostomia: etiology, recognition and treatment. J Am Dent Assoc. 2003;134(1):61-69; quiz 118-119.

    PubMed  Google Scholar 

  11. Greenberg M, Glick M. Immunologic diseases. In: Ciarroca K, Greenberg M, eds. Burket’s Oral Medicine. 10th ed. Hamilton: BC Decker; 2003:491-494.

    Google Scholar 

  12. Wood RE, Lee P. Analysis of the oral manifestations of systemic sclerosis (scleroderma). Oral Surg Oral Med Oral Pathol. 1988;65(2):172-178.

    Article  PubMed  CAS  Google Scholar 

  13. Scardina GA, Messina P. Systemic sclerosis: description and diagnostic role of the oral phenomena. Gen Dent. 2004;52(1):42-47.

    PubMed  Google Scholar 

  14. Albilia JB, Lam DK, Blanas N, et al. Small mouths … Big problems? A review of scleroderma and its oral health implications. J Can Dent Assoc. 2007;73(9):831-836.

    PubMed  Google Scholar 

  15. Garnett MJ, Nohl FS, Barclay SC. Management of patients with reduced oral aperture and mandibular hypomobility (trismus) and implications for operative dentistry. Br Dent J. 2008;204(3):125-131.

    Article  PubMed  CAS  Google Scholar 

  16. Samet N, Tau S, Findler M, et al. Flexible, removable partial denture for a patient with systemic sclerosis (scleroderma) and microstomia: a clinical report and a three-year follow-up. Gen Dent. 2007;55(6):548-551.

    PubMed  Google Scholar 

  17. Oczakir C, Balmer S, Mericske-Stern R. Implant-prosthodontic treatment for special care patients: a case series study. Int J Prosthodont. 2005;18(5):383-389.

    PubMed  Google Scholar 

  18. Patel K, Welfare R, Coonar HS. The provision of dental implants and a fixed prosthesis in the treatment of a patient with scleroderma: a clinical report. J Prosthet Dent. 1998;79(6):611-612.

    Article  PubMed  CAS  Google Scholar 

  19. Raviv E, Harel-Raviv M, Shatz P, et al. Implant-supported overdenture rehabilitation and progressive systemic sclerosis. Int J Prosthodont. 1996;9(5):440-444.

    PubMed  CAS  Google Scholar 

  20. Weinlander M, Krennmair G, Piehslinger E. Implant prosthodontic rehabilitation of patients with rheumatic disorders: a case series report. Int J Prosthodont. 2010;23(1):22-28.

    PubMed  Google Scholar 

  21. Esposito M, Thomsen P, Ericson LE, et al. Histopathologic observations on early oral implant failures. Int J Oral Maxillofac Implants. 1999;14(6):798-810.

    PubMed  CAS  Google Scholar 

  22. Cartsos VM, Zhu S, Zavras AI. Bisphosphonate use and the risk of adverse jaw outcomes: a medical claims study of 714,217 people. J Am Dent Assoc. 2008;139(1):23-30.

    PubMed  Google Scholar 

  23. Hwang D, Wang HL. Medical contraindications to implant therapy: part I: absolute contraindications. Implant Dent. 2006;15(4):353-360.

    Article  PubMed  Google Scholar 

  24. Hwang D, Wang HL. Medical contraindications to implant therapy: part II: relative contraindications. Implant Dent. 2007;16(1):13-23.

    Article  PubMed  Google Scholar 

  25. Elsubeihi ES, Zarb GA. Implant prosthodontics in medically challenged patients: the University of Toronto experience. J Can Dent Assoc. 2002;68(2):103-108.

    PubMed  Google Scholar 

  26. Mealey BL. Periodontal implications: medically compromised patients. Ann Periodontol. 1996;1(1):256-321.

    Article  PubMed  CAS  Google Scholar 

  27. Jolly DE. Interpreting the clinical laboratory. J Calif Dent Assoc. 1995;23(11):32-40.

    PubMed  CAS  Google Scholar 

  28. Javed F, Almas K. Osseointegration of dental implants in patients undergoing bisphosphonate treatment: a literature review. J Periodontol. 2010;81(4):479-484.

    Article  PubMed  CAS  Google Scholar 

  29. Khan AA, Sandor GK, Dore E, et al. Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw. J Rheumatol. 2008;35(7):1391-1397.

    PubMed  Google Scholar 

  30. Lazarovici TS, Yahalom R, Taicher S, et al. Bisphosphonate-related osteonecrosis of the jaw associated with dental implants. J Oral Maxillofac Surg. 2010;68(4):790-796.

    Article  PubMed  Google Scholar 

  31. Madrid C, Sanz M. What impact do systemically administrated bisphosphonates have on oral implant therapy? A systematic review. Clin Oral Implants Res. 2009;20(suppl 4):87-95.

    Article  PubMed  Google Scholar 

  32. Neville B, Damm D, Allen C, et al. Dermatologic diseases. In: Oral and Maxillofacial Pathology. 1st ed. Philadelphia: Saunders; 1995:585-587.

    Google Scholar 

  33. Fox RI, Michelson PE. Head and neck involvement in systemic sclerosis. In: Clements PJ, Furst DE, eds. Systemic Sclerosis. 2nd ed. Philadelphia: Lippincott; 2004:151-161.

    Google Scholar 

  34. Weinstein WM, Kadell BM. The gastrointestinal tract in systemic sclerosis. In: Clements PJ, Furst DE, eds. Systemic Sclerosis. 2nd ed. Philadelphia: Lippincott; 2004:293-308.

    Google Scholar 

  35. Amaechi BT, Higham SM. Dental erosion: possible approaches to prevention and control. J Dent. 2005;33(3):243-252.

    Article  PubMed  CAS  Google Scholar 

  36. Almazrooa SA, Woo SB. Bisphosphonate and nonbisphosphonate-associated osteonecrosis of the jaw: a review. J Am Dent Assoc. 2009;140(7):864-875.

    PubMed  CAS  Google Scholar 

  37. Edwards BJ, Migliorati CA. Osteoporosis and its implications for dental patients. J Am Dent Assoc. 2008;139(5):545-552; quiz 625–626.

    PubMed  Google Scholar 

  38. Nadeau SE. Neurologic manifestations of connective tissue disease. Neurol Clin. 2002;20(1):151-178; vi.

    Article  PubMed  Google Scholar 

  39. Farrell DA, Medsger TA Jr. Trigeminal neuropathy in progressive systemic sclerosis. Am J Med. 1982;73(1):57-62.

    Article  PubMed  CAS  Google Scholar 

  40. Fischoff DK, Sirois D. Painful trigeminal neuropathy caused by severe mandibular resorption and nerve compression in a patient with systemic sclerosis: case report and literature review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;90(4):456-459.

    Article  PubMed  CAS  Google Scholar 

  41. Hietarinta M, Lassila O, Hietaharju A. Association of anti-U1RNP- and anti-Scl-70-antibodies with neurological manifestations in systemic sclerosis (scleroderma). Scand J Rheumatol. 1994;23(2):64-67.

    Article  PubMed  CAS  Google Scholar 

  42. Nascimento IS, Bonfa E, de Carvalho JF, et al. Clues for previously undiagnosed connective tissue disease in patients with trigeminal neuralgia. J Clin Rheumatol. 2010;16(5):205-208.

    Article  PubMed  Google Scholar 

  43. Derk CT, Rasheed M, Spiegel JR, et al. Increased incidence of carcinoma of the tongue in patients with systemic sclerosis. J Rheumatol. 2005;32(4):637-641.

    PubMed  Google Scholar 

  44. Marcucci M, Abdala N. Clinical and radiographic study of orofacial alterations in patients with systemic sclerosis. Braz Oral Res. 2009;23(1):82-88.

    Article  PubMed  Google Scholar 

  45. Marcucci M, Abdala N. Analysis of the masseter muscle in patients with systemic sclerosis: a study by magnetic resonance imaging. Dentomaxillofac Radiol. 2009;38(8):524-530.

    Article  PubMed  CAS  Google Scholar 

  46. Jackowski J, Johren P, Muller AM, et al. Imaging of fibrosis of the oral mucosa by 20 MHz sonography. Dentomaxillofac Radiol. 1999;28(5):290-294.

    Article  PubMed  CAS  Google Scholar 

  47. Tolle SL. Scleroderma: considerations for dental hygienists. Int J Dent Hyg. 2008;6(2):77-83.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag London Limited

About this chapter

Cite this chapter

Hant, F.N., Ravenel, M.C. (2011). A Dentist Inquires About His Patient with Systemic Sclerosis. In: Silver, R., Denton, C. (eds) Case Studies in Systemic Sclerosis. Springer, London. https://doi.org/10.1007/978-0-85729-641-2_32

Download citation

  • DOI: https://doi.org/10.1007/978-0-85729-641-2_32

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-0-85729-640-5

  • Online ISBN: 978-0-85729-641-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics